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Background: Brugada-type ECG changes have been described in association with various cardiac
disease states including electrolyte abnormalities, myocardial pathologies, and mechanical cardiac
abnormalities as well as drug therapies with particular medications. Such potential confounding factors
make it difﬁcult to diagnose Brugada syndrome on the basis of standard guidelines.
Methods: To investigate the incidence of signiﬁcant coronary artery disease in patients with Brugada-
type ECG, coronary angiography was performed in 55 patients with Brugada-type ECGs.
Results: Five of the 55 patients (9%) had signiﬁcant coronary artery stenosis, and 3 out of these 5 were
asymptomatic. Patients with coronary artery disease were older than in those without coronary artery
disease (59.477.2 years vs. 49.0713.8 years, P¼0.03). An electrophysiological study was performed in
4 of the 5 patients, and ventricular ﬁbrillation was induced in all 4.
Conclusions: We conclude that patients with Brugada-type ECGs should be evaluated for coronary artery
disease, and this is especially important for patients in whom age could be a risk factor for the disease.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Brugada syndrome is characterized by ST-segment elevation in
the right precordial leads and sudden cardiac death (SCD) [1]. In
general, the mean age of victims of SCD is approximately 40
years [2]. Brugada syndrome is believed to account for 4–12% of
all cardiac deaths and at least 20% of deaths in patients with a
structurally normal heart [2]. Thus, the timely diagnosis of
Brugada syndrome is clinically imperative. However, myocardial
ischemia can cause right ventricular ST-segment elevation similar
to the Brugada ECG pattern [3–7], and the coexistence of Brugada
syndrome with vasospastic angina has been reported [8–12]. In
addition, Brugada syndrome has been reported to associate with
individual cases of signiﬁcant coronary artery stenosis [13–17].
Thus, Brugada syndrome cannot be diagnosed simply on the basis
of standard guidelines if such potential confounding factors are
present [2,7]. The present retrospective study was undertaken
to evaluate the coexistence of Brugada syndrome and coronary
artery disease in a single center.rt Rhythm Society. Published by E
y, Department of Medicine,
chi-kamimachi, Itabashi-ku,
; fax: þ81 3 3972 1098.
I. Watanabe).2. Materials and methods
2.1. Patients
The subjects in this study included 55 consecutive patients
with a spontaneous or drug-induced (pilsicainide 1 mg/kg) Bru-
gada type 1 ECG pattern. The ECG diagnosis of Brugada syndrome
was based on recommendations issued at the second consensus
conference [2]. No patients with true right bundle branch block
were included in the study. All 55 patients underwent transthor-
acic echocardiography, cardiac catheterization, coronary angio-
graphy, and left and right ventricular angiography, while 54 of the
55 patients also underwent an electrophysiological study. All
study protocols (coronary angiography including coronary spasm
induction by intracoronary administration of acetylcholine and
electrophysiological studies) were approved by the Clinical
Research Committee of Nihon University Hospital, and written
informed consent was obtained from all patients.
Laboratory tests were performed at the outpatient clinic to
exclude electrolyte or metabolic disturbances. The following
clinical data were obtained from each patient’s record: sex, age,
symptom(s), family history of SCD (o45 years of age), ECG
pattern (type 1, type 2, or type 3 before drug challenge test),
and whether an implantable cardioverter-deﬁbrillator (ICD)lsevier B.V. All rights reserved.
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aborted SCD were considered symptomatic. Those with estab-
lished neurally mediated syncope were not considered sympto-
matic. Screening for mutations in the SCN5A gene was performed
in 37 individuals after approval of the internal review board of the
Nihon University School of Medicine and Nihon University
Hospital.2.2. Signal-averaged electrocardiogram
A ventricular signal-averaged electrocardiogram (ART 1200
EPX signal-averaged ECG apparatus, Arrhythmia Research Tech-
nology Inc., Austin, TX, USA; noise levelo0.3 mV, bidirectional
4-pole Butterworth high pass ﬁlter setting of 40 Hz) was recorded
in 52 patients. A positive late potential is deﬁned at our institution
as the root mean square voltage of the last 40 mso20 mV [18].2.3. Electrophysiological study
A comprehensive electrophysiological study was performed
on 54 patients in a fasting, drug-free, and non-sedated state. In
patients who underwent coronary artery stent implantation, a
programmed ventricular stimulation (PVS) study was performed
for 1 month. After access to the right femoral vein was obtained at
4 sites, 1 quadripolar catheter (Biosense-Webster, Diamond Bar,
CA, USA) was positioned at the right atrial appendage, 1 octapolar
catheter (Biosense-Webster) was positioned at the His bundle
electrogram recording site, and 2 steerable quadripolar catheters
(6F) with an interelectrode distance of 2-5-2 mm (Biosense-
Webster) were positioned in the right ventricular apex and
outﬂow tract. The endocardial potentials were ﬁltered to record-
ing frequencies of 30–500 Hz and recorded on a BARD computer
system (BARD Lab Pro, BARD Electrophysiology, Lowell, MA, USA).
Programmed electrical stimulation from the right ventricular
apex and right ventricular outﬂow tract was performed at
strength of twice the diastolic threshold, and a 2-ms pulse was
applied with a pulse generator (BD-02, Fukuda Denshi Co., Tokyo,
Japan). An S1S2 interval was applied after 8 beats of drive pacing
(S1) at basic cycle lengths of 600 ms and 400 ms. The S1S2
interval was decreased in 10-ms steps until the effective refrac-
tory period of the right ventricle was reached. When ventricular
ﬁbrillation (VF) that lasted 45 s and required direct current (DC)
shock was not induced with a single premature beat,Table 1
Clinical, genetic, electrocardiographic, and electrophysiological characteristics of all pa
Total patients N¼55 Patien
Number of males 53 5 (10
Age (years) 50.4713.8 (24–79) 59.47
Symptomatic 10 1 (20
Family history of SCD 7 0
Spontaneous type 1 ECG pattern 31 1 (20
Late potentials 27 2 (40
SCN5A gene mutation 2 0
PR interval (ms) 172.1724.9 170.8
QTc (ms) 413.3722.8 401.2
QRS duration (ms) 106.7717.6 102.4
EPS 54 4
AH (ms) 101.5720.0 126.3
HV (ms) 47.8710.4 37.07
Inducible VF/PVT upon EPS 49/55 (89.1%) 4/4 (1
ICD implantation 19 1
Follow-up (months) 81.0747.5 67.17
Arrhythmic event during follow-up 1 0
The number of patients is shown unless otherwise indicated. CAD, coronary artery dis
ﬁbrillation; PVT, polymorphic ventricular tachycardia; ICD, implantable cardioverter d3 extrastimuli (S2 until the effective refractory period was
reached, S3 and S4 to 180 ms) were delivered.
2.4. Follow-up
In general, patients were followed up at 4- to 5-month
intervals in our outpatient clinic. Each examination included an
assessment of subjective symptoms, 12-lead ECG, and device
interrogation if necessary in the event of symptom onset or
device discharge. The follow-up period ranged from 6 to 194
months (mean, 81.0747.5 months; median, 77 months).
2.5. Statistical analysis
Continuous clinical and electrophysiological values are shown
as mean7SD. Between-group differences in these values were
analyzed by the Mann–Whitney U test. Categorical data were
analyzed by Fisher’s exact probability test. A P value of o0.05
was considered statistically signiﬁcant. StatView 5.0 software
(SAS Institute, Cary, NC, USA) was used for analysis.3. Results
The male/female sex ratio in the study group was 53/2, and
the mean age was 50.4713.8 years (range, 24–79 years). Brugada
syndrome ECG patterns were spontaneous type 1 (n¼31) and drug-
induced type 1 (n¼24; type 2¼14, type 3¼10). The clinical, genetic,
electrocardiographic, and electrophysiological characteristics of the
study patients are shown in Table 1. Eleven patients were sympto-
matic (3 with history of syncope, 2 with presyncope, and 6 with
aborted SCD), and 5 patients had a positive family history of SCD.
An SCN5A gene mutation was found in 2 patients (5.4%). The left
ventriculogram was normal with an ejection fraction of 69.2%79.0%
(55–89%) in 55 patients who had undergone left ventricular angio-
graphy. The coronary angiogram, although normal in 49 patients,
revealed signiﬁcant coronary artery disease in 5 patients. Risk factors
in patients with coronary artery disease are listed in Table 2. Patients
with coronary artery disease were older than those without coronary
artery disease (59.477.2 years vs. 49.0713.8 years, P¼0.03)
(Table 1). Two of the 5 patients (Patients 2 and 4) exhibited
symptoms related to coronary artery disease. PVS was performed in
50 patients without signiﬁcant coronary artery stenosis and in 4 of
the 5 patients with coronary artery disease, which induced VF/tients and patients with and without Coronary Artery Disease (CAD).
ts with CAD (n¼5) Patients without CAD (n¼50) P value
0%) 48 (96.0%) 0.86
7.2 49.0713.8 0.03
.0%) 9 (18.0%) 0.83
7 (14.0%) 0.65
.0%) 30 (60.0%) 0.11
.0%) 25 (50.0%) 0.64
2 (4.0%) 0.86
715.2 172.2725.8 0.99
714.1 414.5723.3 0.23
716.1 107.2717.8 0.84
50 0.87
726.8 99.5718.3 0.03
2.2 48.7710.3 0.19
00%) 45/50 (90.0%) 0.17
18 0.17
50.6 80.2749.4 0.22
1 (1.5%) 40.99
ease; SCD, sudden cardiac death; EPS, electrophysiological study; VF, ventricular
eﬁbrillator.
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(90%) without coronary artery disease and in the 4 patients with
coronary artery disease (Table 2). Details regarding the electrophy-
siological data and the coronary angiogram are provided in Table 3.
An ICD was implanted in 19 patients who had inducible PVT/VF and
desired an ICD implant (38.8%). Two representative cases of coronary
artery disease are described below.
3.1. Patient 1
This patient was a 71-year-old man who had undergone right
artiﬁcial hip replacement surgery for arthritis deformans at our
orthopedics department. After his surgery, we observed fre-
quent ventricular premature beats on the ECG monitor, and we
noted an incomplete right bundle branch block and STT eleva-
tion (type 2 Brugada ECG) on the 12-lead ECG (Fig. 1, left and
middle). A pilsicainide challenge test was performed, and the
ECG changed to a type 1 pattern in leads V1 and V2 (Fig. 1, right).
The coronary angiogram (CAG) revealed 90% stenosis of the
proximal left anterior descending coronary artery (LAD) (seg-
ment ]7), 99% stenosis of the middle portion of the right
coronary artery (RCA) (segment ]3), and total occlusion of the
posterior descending (PD) coronary artery (Fig. 2 upper panel). A
stent was implanted in LAD segment ]7. Programmed ventri-
cular stimulation was performed 1 month later, and VF was
induced by double extrastimuli from the right ventricular apex
(S1: 400 ms, S2: 230 ms, S3: 200 ms). Thus, an ICD was implanted
Table 3.Table 2
Risk factors for Brugada syndrome patients with coronary artery disease.
Patient Age
(years)
Sex FH BMI HT Dyslipidemia DM Brinkman
Index
1 71 male  22.0 þ  þ 1000
2 54 male  17.6    560
3 58 male  25.8  þ þ 0
4 53 male  23.9 þ þ þ 0
5 61 male  19.7  þ  0
FH, family history of the coronary heart disease; BMI, body mass index; HT,
hypertension; DM, diabetes mellitus; Brinkman Index, number of cigarettes
smoked per daynumber of years of smoking.
Twelve-lea
Baseline
I V1
II V2
III V3
aVR V4
aVL V5
1 V
aVF V6
m
Fig. 1. Twelve-lead ECG from Patient 1. Note the type 2 Brugada pattern in the right
intravenous administration of 1 mg/kg pilsicainide (right panel).3.2. Patient 2
This patient was a 54-year-old man who had anterior chest
discomfort and visited another hospital. His 12-lead ECG showed
an incomplete right branch block and ST elevation (type 2 Brugada
ECG) (Fig. 3, left), and he was referred to our hospital. An
emergency CAG indicated 90% stenosis of the second diagonal
branch (segment ]10) of the LAD. No percutaneous intervention
was performed. PVS was performed and VF was induced by
double extrastimuli from the right ventricular outﬂow tract (S1:
600 ms, S2: 230 ms, S3: 200 ms).
3.3. Patient 3
This patient was a 53-year-old man who was hospitalized at
the Neurology Division due to cerebral infarction. Upon his
admission, a 12-lead ECG showed an incomplete right branch
block and ST elevation (type 2 Brugada ECG) (Fig. 3, middle).
A CAG and a PVS were performed prior to discharge. The CAG
revealed total occlusion of the left circumﬂex coronary artery
branch (]13). VF was induced by double extrastimuli from the
right ventricular apex (S1: 400 ms, S2: 210 ms, S3: 190 ms).
3.4. Patient 4
This patient was a 58-year-old man who had anterior chest
pain and visited his family doctor. A 12-lead ECG showed an
incomplete right branch block and STT elevation (type 1 Brugada
ECG) (Fig. 3, right). He was referred to our hospital because
acute coronary syndrome was suspected. An emergency CAG
revealed 90% stenosis of the LAD (segment ]7), 90% stenosis of
LCX segment ]13, and 50% stenosis of segment ]14. A coronary
stent was implanted in LAD segment ]7. PVS was performed
3 months later, and VF was induced by double extrastimuli from
the right ventricular outﬂow tract (S1: 400 ms, S2: 210 ms, S3:
200 ms).
3.5. Patient 5
This patient was a 61-year-old man who underwent laryn-
gectomy for laryngeal cancer in our otolaryngology department.Patient 1d ECG
After Pilsicainide
V1
V2
V3
V4
V5
V6
1 mV
precordial leads (left and middle panels), which was altered to a type 1 ECG by
Table 3
Clinical characteristics of Brugada syndrome patients with coronary artery disease.
Patient Age (years) Sex ECG FH LP VF induction (ms) CAG PCI ICD
1 71 Male Type 2   A: 400/230/200 4PD: total RCA ]3: 99%, LAD ]7: 90% þ þ
2 54 Male Type 2  þ O: 600/230/200 LAD D2: 90%  
3 58 Male Type 2  þ A: 400/210/190 CX ]13: total  
4 53 Male Type 1   O: 400/210/200 LAD ]7: 90% LCX ]13: 90% LCX ]14: 50% þ 
5 61 Male Type 3   Not performed LAD ]7: 90% þ 
ECG, Brugada type ECG; FH, family history of sudden cardiac death; LP, late potentials; VF, ventricular ﬁbrillation; CAG, coronary angiogram; PCI, percutaneous coronary
intervention; ICD, implantable cardioverter deﬁbrillator; A, right ventricular apex; O, right ventricular outﬂow tract; LAD, left anterior descending coronary artery; RCA,
right coronary artery; CX, left circumﬂex coronary artery; PD, posterior descending coronary artery.
Fig. 2. Right precordial lead ECGs from patients 2–4. Note that patients 2 and 3 showed a type 2 Brugada ECG, and patient 4 showed a type 1 Brugada ECG.
RCA LAD After LAD stent placement
Coronary Angiogram
Patient 1
RCA LAD After LAD stent placement  Patient 5
Fig. 3. Coronary angiogram obtained from Patient 1 (upper panels). Note the 90% stenosis of the proximal portion of the left descending coronary artery (segment ]7), the
99% stenosis of the middle portion of the right coronary artery (segment ]3), and the total occlusion of the posterior descending coronary artery. Coronary angiogram
obtained from Patient 5 (lower panels). Note the 90% stenosis of the proximal portion of the left anterior descending coronary artery (segment ]7).
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and he was admitted to our hospital for dilatation of thetracheostomy ﬁstula. Upon his admission, a 12-lead ECG showed
an incomplete right bundle branch block and J point elevation in
Twelve-lead ECG Patient 5
I V1
V1
Baseline After Pilsicainide
II V2
V2
III V3 V3
aVR V4 V4
aVL V5 V5
1 mv
aVF V6 1 mV V6
Fig. 4. Twelve-lead ECG from Patient 5. Note the type 3 Brugada pattern in the right precordial leads (left and middle panels), which was altered to a type 1 ECG by
intravenous administration of 1 mg/kg pilsicainide (right panel).
Monomorphic Ventricular Tachycardia 
After Pilsicainide Administration
Patient 5
After Isoproterenol
I V1 V1
II V2 V2
III V3 V3
aVR V4 V4
aVL V5
1 mv
V5
1 mv
aVF V6
V6
Fig. 5. Monomorphic ventricular tachycardia developed after pilsicainide administration in Patient 5 (left and middle panels). Normalization of ST-segment elevation in
the right precordial leads was observed after infusion of isoproterenol.
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challenge test was performed, and the ECG changed to a type
1 Brugada pattern (Fig. 4, right), which was followed by mono-
morphic ventricular tachycardia (136 beats/minute) with a right
bundle branch block pattern (Fig. 5, left). The ventricular tachy-
cardia terminated spontaneously, and the STT changes in the right
precordial leads resolved with intravenous infusion of isoproter-
enol (Fig. 5, right). A coronary angiogram indicated 90% stenosis of
the proximal LAD (segment ]7); thus, a stent was implanted
(Fig. 2, lower panel). The patient refused electrophysiological study
and ICD implantation. The exact mechanism of the ventricular
tachycardia was unknown, but Ueyama et al. reported a similar case
in which ventricular tachycardia originated from the left posterior
fascicle [19].
Patients 2 and 3 were administered aspirin, and patients 1, 2, and
4 were administered dual antiplatelet therapy (aspirinþclopidogrel).
The ECG pattern did not change signiﬁcantly during follow-up Fig. 5.3.6. Follow-up
No deaths occurred during the follow-up period. One patient
without coronary artery disease suffered an arrhythmic event
during follow-up for 4 months.4. Discussion
In our patient series, coronary angiography was performed
routinely prior to electrophysiological study, revealing a 9.1%
(5/55) incidence of signiﬁcant coronary artery stenosis in patients
with Brugada syndrome/Brugada-type ECG. Although acute myo-
cardial ischemia has been reported to cause right ventricular
ST-segment changes similar to the Brugada-type ECG pattern
[3–7] and coexistence of Brugada syndrome and vasospastic
angina has been reported [8–12], only a few individual case
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onary artery stenosis and Brugada syndrome [13–17]. Seow et al.
[20] reported an interesting patient who presented with atypical
chest pain, and the initial ECG showed a Brugada type 1 pattern.
Subsequent ECGs depicted evolving anterior ST elevation myo-
cardial infarction. The presence of a Brugada type 1 pattern
masked the ECG changes indicative of acute anterior myocardial
infarction, which made the diagnosis difﬁcult. Hata et al. [21]
described a patient who died suddenly due to VF documented by
Holter monitoring, and a review of the patient’s medical record
revealed a Brugada type 2 ECG pattern. The autopsy revealed
complete occlusion of the left main coronary artery. Ogano et al.
[22] reported 2 asymptomatic patients with a saddleback
Brugada-type ECG that dynamically converted to a coved-type
pattern following ventricular arrhythmia episodes when myocar-
dial ischemia occurred exclusively at the conus branch of the right
coronary artery. These reports suggest that acute myocardial
ischemia can mimic a Brugada-type ECG (and vice versa) and
also that acute myocardial ischemia exacerbates the Brugada-
type ECG pattern and has proarrhythmic effects. Therefore,
coronary artery disease/ischemic heart disease should be consid-
ered when risk is being evaluated in patients with Brugada
syndrome/Brugada-type ECG. According to the revised version
of the ‘‘Guidelines for the primary prevention of ischemic heart
disease’’ (JCS 2006 online only), the prevalence of ischemic heart
disease in man was 8.13/1000 and 11.8/1000 in 2 cohort studies.
It is very difﬁcult to compare the prevalence of coronary artery
disease between Brugada syndrome and non-Brugada syndrome
because no data is available on the prevalence of coronary artery
disease in the asymptomatic Japanese population, and many
studies have indicated the annual incidence of ischemic heart
disease in large cohort studies. As mentioned above, 2 studies
have demonstrated the prevalence of coronary heart disease in
Japanese men (8.13/1000 and 11.8/1000) [23,24]. In the present
study, the incidence of coronary heart disease was 9.1%, which is
almost 10 times higher than what was observed in previous
studies. However, our study group included 2 patients with chest
pain/oppression. Therefore, our results were slightly biased and
could be merely coincidental. Unquestionably, age is related to
risk, and remarkably, clinical, electrocardiographic, and electro-
physiological characteristics were not statistically different in our
patients with coronary artery disease compared to those without
the disease.
4.1. Study limitations
In our patients, the Brugada-type ECG pattern did not change
after coronary artery intervention or during follow-up under
antiplatelet and antianginal drug therapies. Therefore, the rela-
tionship between Brugada syndrome and coronary artery disease
was undeﬁned. Additionally, the effects of ischemia on the
Brugada-type ECG pattern and the effects of the Brugada-type
ECG on the ischemia-induced ECG changes were not clariﬁed.5. Conclusion
We conclude that patients with a Brugada-type ECG should be
evaluated for coronary artery disease. This is particularly true for
patients in whom age could be a risk factor for the disease.References
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